Drugs / PEGIFNα1b
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05639803 | Jul → Oct 2020 | herpes zoster | Shanghai Institute Of Biological Products | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PEGIFNα1b | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05639803 ↗ |
| Route | Subcutaneous | “subcutaneous administered” NCT05639803 ↗ |